Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.
恩替诺特、纳武利尤单抗和伊匹木单抗治疗晚期 HER2 阴性乳腺癌女性：一项 Ib 期试验
期刊:Nature Cancer
影响因子:28.5
doi:10.1038/s43018-024-00729-w
Roussos Torres Evanthia T, Ho Won J, Danilova Ludmila, Tandurella Joseph A, Leatherman James, Rafie Christine, Wang Chenguang, Brufsky Adam, LoRusso Patricia, Chung Vincent, Yuan Yuan, Downs Melinda, O'Connor Ashley, Shin Sarah M, Hernandez Alexei, Engle Elizabeth L, Piekarz Richard, Streicher Howard, Talebi Zahra, Rudek Michelle A, Zhu Qingfeng, Anders Robert A, Cimino-Mathews Ashley, Fertig Elana J, Jaffee Elizabeth M, Stearns Vered, Connolly Roisin M
